Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its distribution is strictly regulated by https://apo-lisdexamfetamine-for583439.angelinsblog.com/41833312/lisdexamfetamine-in-canada-a-complete-guide